Certified by Founder Lodge
Avoro Capital Advisors
United States - New York
INVESTOR
1 Disclosed Funding Rounds $135,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Global life sciences firm focused on investments in biotechnology and specialty therapeutics.
| Company | Date | Round | Raised |
|---|---|---|---|
 Hemab Therapeutics |
February, 22 ,2023 | Series B | $135,000,000 |
 Vicebio |
September, 24 ,2024 | Series B | $100,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
WealthAi | $1,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
